Combining-Quetiapine-Aripiprazole

From Psychiatrienet
Revision as of 14:02, 8 June 2010 by Mariska (talk | contribs)
Jump to: navigation, search
Quetiapine
Type antipsychotic
Group atypical AP
Other use moodstabilizer
links
ATC-code N05AH04
Medscape Quetiapine
PubChem 5002
PubMed Quetiapine
Drugs.com quetiapine-fumarate
Kompas (Dutch) Quetiapine
Wikipedia Quetiapine
Ariprazole
Type Antipsychotic
Group Atypical AP
Other use moodstabilizer
links
EMEA abilify
PubChem 60975
PubMed Ariprazole
Kompas (Dutch) Ariprazole
Wikipedia Ariprazole

Adding aripiprazole to quetiapine.

Infobord.png General information
  • Quetiapine is principally metabolized by CYP3A4 to active and inactive metabolites.
  • Aripiprazole is metabolized by CYP2D6 and CYP3A4 to an active metabolite.
  • There is no evidence published related to this drug combination recently. The combination will have additive side effects.
Eenrichtingbord.png Start aripiprazole
  • Start aripiprazole according to the general dosing advice.
Letopbord.png Cave
  • Agents with anticholinergic properties may have additive effects when used in combination. [4]


  1. 1.0 1.1 1.2 KNMP; Informatorium Medicamentorum 2023; Monografie "quetiapine" (Dutch)
  2. NVZA; Toxicology.org; Monografie 73 (dutch)
  3. Woods SW Chlorpromazine equivalent doses for the newer atypical antipsychotics J Clin Psychiatry 2003;64:663-667
  4. 4.0 4.1 Drugs.com quetiapine-fumarate Cite error: Invalid <ref> tag; name "drugscom" defined multiple times with different content
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.